Literature DB >> 1967491

What excitotoxin kills striatal neurons in Huntington's disease? Clues from neurochemical studies.

T L Perry1, S Hansen.   

Abstract

Amino acid analyses of both caudate nucleus and putamen obtained at autopsy from patients dying with Huntington's disease (HD), and from control subjects, showed significantly decreased mean glutamate contents in the HD patients. In addition, the mean glutamate concentration was significantly increased in the CSF of living HD patients as compared with controls. Neurochemical studies also showed that neither aspartic acid, proline, 5-oxoproline, nor homocysteic acid is likely to act as a causative excitotoxin in HD. Excessive striatal glycine content, or deficient glutathione content, is unlikely to contribute to the effects of a causative excitotoxin in HD. We suggest that glutamic acid may be the proximate causative neurotoxin in the striatum in HD, as a result of an unexplained failure in the reuptake mechanism for glutamate released there as an excitatory neurotransmitter.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1967491     DOI: 10.1212/wnl.40.1.20

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  12 in total

1.  Lower levels of glutathione in the brains of secondary progressive multiple sclerosis patients measured by 1H magnetic resonance chemical shift imaging at 3 T.

Authors:  I-Y Choi; S-P Lee; D R Denney; S G Lynch
Journal:  Mult Scler       Date:  2010-10-04       Impact factor: 6.312

Review 2.  Reactive oxygen/nitrogen species and their functional correlations in neurodegenerative diseases.

Authors:  Mahesh Ramalingam; Sung-Jin Kim
Journal:  J Neural Transm (Vienna)       Date:  2012-01-04       Impact factor: 3.575

3.  Neurochemical correlates of caudate atrophy in Huntington's disease.

Authors:  Jeannie M Padowski; Kurt E Weaver; Todd L Richards; Mercy Y Laurino; Ali Samii; Elizabeth H Aylward; Kevin E Conley
Journal:  Mov Disord       Date:  2014-01-17       Impact factor: 10.338

Review 4.  The development of mitochondrial medicine.

Authors:  R Luft
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

Review 5.  Neurotoxins and neurotoxic species implicated in neurodegeneration.

Authors:  Juan Segura Aguilar; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

6.  Creatine supplementation lowers brain glutamate levels in Huntington's disease.

Authors:  Andreas Bender; Dorothee P Auer; Thomas Merl; Ralf Reilmann; Phillip Saemann; Alexander Yassouridis; Julia Bender; Adolf Weindl; Matthias Dose; Thomas Gasser; Thomas Klopstock
Journal:  J Neurol       Date:  2005-01       Impact factor: 4.849

7.  Glutamine synthetase gene expression and glutamate transporters in C6-glioma cells.

Authors:  Zafeer Baber; Nasrin Haghighat
Journal:  Metab Brain Dis       Date:  2010-11-25       Impact factor: 3.584

8.  Compartmentalization of excitatory amino acid receptors in human striatum.

Authors:  L S Dure; A B Young; J B Penney
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

9.  Enhanced [3H] glutamate binding in the cerebellum of insulin-induced hypoglycaemic and streptozotocin-induced diabetic rats.

Authors:  Anu Joseph; Remya Robinson; C S Paulose
Journal:  Cell Mol Neurobiol       Date:  2007-09-06       Impact factor: 5.046

Review 10.  Of mice, rats and men: Revisiting the quinolinic acid hypothesis of Huntington's disease.

Authors:  Robert Schwarcz; Paolo Guidetti; Korrapati V Sathyasaikumar; Paul J Muchowski
Journal:  Prog Neurobiol       Date:  2009-04-24       Impact factor: 11.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.